Chronic rhinosinusitis (CRS) occurs in> 10% of the adult population in Europe and the USA
and can be differentiated into CRS without nasal polyps and CRS with nasal polyps …

Severe chronic rhinosinusitis with nasal polyps (CRSwNP) is a debilitating disease with a
significant impact on the quality of life (QoL). It is typically characterized by a type 2 …

Uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) is the most
bothersome phenotype of chronic rhinosinusitis; it is typically characterized by a type 2 …

Objective This narrative review analyses factors affecting recurrence of Chronic
rhinosinusitis with nasal polyps (CRSwNP) after surgery, such as type, extension and …

Background Chronic rhinosinusitis with nasal polyps is frequently managed with endoscopic
sinus surgery (ESS). Prior studies describe individual clinical variables and eosinophil …

Background In the Phase III SYNAPSE study, mepolizumab reduced nasal polyp (NP) size
and nasal obstruction in chronic rhinosinusitis with NP (CRSwNP). Objective To assess the …

Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory
disease treated with sinus surgery when refractory to medical intervention. However …

Objective Both endoscopic sinus surgery (ESS) and biologic therapies have shown
effectiveness for medically‐refractory chronic rhinosinusitis with nasal polyps (CRSwNP) …

Background Comparative effectiveness research between endoscopic sinus surgery (ESS)
and biologic therapy for severe chronic rhinosinusitis with nasal polyposis (CRSwNP) is a …

Biologic therapy is a new treatment option for patients with chronic rhinosinusitis with nasal
polyps (CRSwNP). Currently, the only biologic with Food and Drug Administration–approval …